Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,350 | -65,336 | -65,321 | -36,210 | -25,174 |
| Depreciation Amortization | 572 | 874 | 983 | 995 | 1,044 |
| Accounts receivable | -5,000 | N/A | 152 | 610 | -153 |
| Accounts payable and accrued liabilities | -600 | -516 | -2,327 | 2,686 | 667 |
| Other Working Capital | -4,481 | -781 | 7,132 | 13,129 | 427 |
| Other Operating Activity | 13,424 | 6,598 | 7,355 | -967 | 726 |
| Operating Cash Flow | $-51,435 | $-59,161 | $-52,026 | $-19,757 | $-22,463 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 154 | 26,057 | -1,369 | -21,516 | -3,516 |
| PPE Investments | 75 | -785 | -729 | -584 | -1,163 |
| Investing Cash Flow | $229 | $25,272 | $-2,098 | $-22,100 | $-4,679 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 20,957 | N/A | 13,766 |
| Debt Repayment | -2,800 | N/A | -12,934 | N/A | -2,336 |
| Common Stock Issued | 32,126 | 697 | 10,886 | 71,762 | 109 |
| Other Financing Activity | 75,715 | 0 | 47,114 | -4,103 | 32,367 |
| Financing Cash Flow | $105,041 | $697 | $66,023 | $67,659 | $43,906 |
| Exchange Rate Effect | 34 | -153 | 78 | 463 | -1,019 |
| Beginning Cash Position | 37,682 | 71,027 | 59,050 | 32,785 | 16,592 |
| End Cash Position | 91,551 | 37,682 | 71,027 | 59,050 | 32,337 |
| Net Cash Flow | $53,869 | $-33,345 | $11,977 | $26,265 | $15,745 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,435 | -59,161 | -52,026 | -19,757 | -22,463 |
| Capital Expenditure | -47 | -884 | -733 | -586 | -1,163 |
| Free Cash Flow | -51,482 | -60,045 | -52,759 | -20,343 | -23,626 |